Fig. 1From: Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic functionStudy flowchart. SGLT2i, Sodium-glucose cotransporter type 2 inhibitorBack to article page
